![Lars Rebien Sørensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Rebien Sørensen
Chairman at
NOVO NORDISK A/S
Profile
Mr. Lars Rebien Sørensen is a Chairman at Novo Holdings A/S, a Chairman at Novo Holdings A/S, an Independent Director at Essity AB, an Independent Director at Thermo Fisher Scientific, Inc. and a Chairman at Novo Nordisk Fonden. He is on the Board of Directors at Essity AB, Thermo Fisher Scientific, Inc. and Jungbunzlauer AG. He has over 34 years of general management experience in the pharmaceutical industry. He joined the Novozymes A/S (then Novo Nordisk A/S, Enzymes Division) marketing team in 1982. Over the years he held various global positions across the Middle East and the United States. In 1994, he was appointed a member of the corporate management team and assumed responsibility for the Novozymes A/S healthcare business. In November 2000 he became President and CEO of Novo Nordisk A/S, a position he held until December 2016. He received an MSc in Forestry from the Copenhagen Royal Veterinary and Agricultural University in 1981 and a BSc in International Economics from Copenhagen Business School in 1983.
Latest news about Lars Rebien Sørensen
Lars Rebien Sørensen active positions
| Companies | Position | Start |
|---|---|---|
| NOVO NORDISK A/S | Chairman | 2025-11-13 |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Chairman | 2018-06-30 |
Ferring Holding SA
 Ferring Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and markets pharmaceutical products for reproductive, maternal health & urology | Director/Board Member | 2024-04-07 |
Ferring International Center SA
 Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Chairman | 2021-06-30 |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Director/Board Member | 2022-12-31 |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Chairman | 2018-06-30 |
Jungbunzlauer Suisse AG
 Jungbunzlauer Suisse AG Food: Major DiversifiedConsumer Non-Durables Produces biodegradable ingredients | Director/Board Member | - |
Former positions of Lars Rebien Sørensen
| Companies | Position | End |
|---|---|---|
Novo Holdings A/S (Denmark)
 Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Chairman | 2025-10-31 |
| THERMO FISHER SCIENTIFIC, INC. | Director/Board Member | 2024-05-21 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Lars Rebien Sørensen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
95
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Bertelsmann SE & Co. KGaA
 Bertelsmann SE & Co. KGaA Movies/EntertainmentConsumer Services Provides entertainment, radio broadcasting, book publishing, music and education services | Consumer Services |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology Develops protein based drugs | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Svenska Cellulosa AB SCA
 Svenska Cellulosa AB SCA Pulp & PaperProcess Industries Offers paper for packaging and print, pulp, wood products, renewable energy, services for forest owners and efficient transport solutions | Process Industries |
Carlsberg A/S
 Carlsberg A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beers and soft drinks | Consumer Non-Durables |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Miscellaneous |
Novo Holdings A/S (Denmark)
Novo Holdings A/S (Denmark) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Produces and markets beer & soft drinks | Consumer Non-Durables |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Health Technology |
Danmarks Nationalbank
 Danmarks Nationalbank Major BanksFinance Danish central bank | Finance |
Ørsted A/S
 Ørsted A/S Electric UtilitiesUtilities Develops, constructs and operates offshore and onshore wind farms, solar farms, energy storage facilities, renewable hydrogen and green fuels facilities and bioenergy plants | Utilities |
Cameron Services AG
 Cameron Services AG Food: Major DiversifiedConsumer Non-Durables Produces natural and nature-identical biodegradable ingredients like citric acids and salts | Consumer Non-Durables |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ferring Holding SA
Ferring Holding SA Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops and markets pharmaceutical products for reproductive, maternal health & urology | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Ferring International Center SA
Ferring International Center SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets products in the fields of urology, gynaecology and obstetrics | Health Technology |
Novo Nordisk (Private Equity)
 Novo Nordisk (Private Equity) Investment ManagersFinance NNBF invests equity into promising young companies in the health science industry, with a focus on Europe and North America. Their investment strategy focuses on start-ups and later stage biotech firms with a high level of relevance for Novo Nordisk's business model. NNBF focuses on Inflammation, Diabetes, Obesity, Haemostasis, Protein Delivery Systems and Devices, along with Enabling Technologies supporting relevant therapeutic areas. | Finance |
Bertelsmann Management SE
 Bertelsmann Management SE BroadcastingConsumer Services Operates as a holding company whose subsidiaries provides media, book publishing and educational services | Consumer Services |
Essity Germany GmbH
 Essity Germany GmbH Household/Personal CareConsumer Non-Durables Manufactures, markets and distributes personal care, consumer tissue and professional hygiene products | Consumer Non-Durables |
Essity AB
 Essity AB Household/Personal CareConsumer Non-Durables Manufactures and retails personal & home hygiene, baby and feminine care and consumer tissue products | Consumer Non-Durables |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Jungbunzlauer Suisse AG
Jungbunzlauer Suisse AG Food: Major DiversifiedConsumer Non-Durables Produces biodegradable ingredients | Consumer Non-Durables |
- Stock Market
- Insiders
- Lars Rebien Sørensen
